Kiora Pharmaceuticals Inc
KPRX2.050USD
-0.070-3.30%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
7.04MMarket Cap
LossP/E TTM
Kiora Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
16.02M
--
EPS(YoY)
0.93
103.83%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 16.02M, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.928, with a year-on-year change of 103.83%.
What is the net income of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its net income was 3.59M, with a year-on-year change of 127.56%.
What is the net margin of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was 22.44%, with a year-on-year change of --.
What is the gross margin of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was 22.56%, with a year-on-year change of 115.15%.
What is the Return on Assets (ROA) of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was 14.32%, with a year-on-year change of 118.54%.
What is the operating profit of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 5.58M, with a year-on-year change of 164.22%.
What are the current assets of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its current assets were 29.71M, with a year-on-year change of 526.97%.
What are the total assets of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its total assets of Kiora Pharmaceuticals Inc were 36.48M, with a year-on-year change of 166.08%.
What are the total liabilities of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Kiora Pharmaceuticals Inc were 10.72M, with a year-on-year change of 41.07%.
What is the total equity of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its total equity of Kiora Pharmaceuticals Inc was 25.76M, with a year-on-year change of 321.62%.
What is the net operating income of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Kiora Pharmaceuticals Inc was 3.59M, with a year-on-year change of 128.73%.
What is the net investment of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its net investment of Kiora Pharmaceuticals Inc was -22.66M, with a year-on-year change of --.
What is the net financing of Kiora Pharmaceuticals Inc?
According to Kiora Pharmaceuticals Inc's FY2024 earnings report, its net financing of Kiora Pharmaceuticals Inc was 15.50M, with a year-on-year change of 159.77%.
